companydata.dkcompanydata.dk

Neural Stem Cell ApS: Financial statements 2024

CVR: 43710273

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Neural Stem Cell ApS (CVR 43710273) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1 and a net result of DKK -1,334 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 38,666. The solvency ratio was 52.6%.

Profit/Loss
DKK -1,334
Equity
DKK 38,666
Total Assets
DKK 73,486
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--1-1K39K0
2023-0040K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Neural Stem Cell ApS: The 2023 annual report is outJul 11, 2024

Neural Stem Cell ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 0.

About Neural Stem Cell ApS

Neural Stem Cell ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Brian Taammoli. The company is owned by Brian Taammoli. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,278 and a net result of DKK -51,093 compared with DKK -1,334 the year before. Equity in the 2025 report amounted to DKK -12,427.

Source: annual report 2025, Danish Business Authority

Other financial years